Atai Life Sciences N.V. (ATAI)

Atai Life Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	29.96	45.03	190.61	362.27	97.25	30.06
Short-Term Investments	55.96	134.22	82.5	-	-	-
Cash & Short-Term Investments	85.92	179.26	273.11	362.27	97.25	30.06
Cash Growth	-58.89%	-34.36%	-24.61%	272.53%	223.48%	-
Other Receivables	1.25	1.75	5.63	5.41	1.07	0.46
Receivables	6.95	2.26	5.63	6.32	1.29	8.7
Prepaid Expenses	1.07	1.41	2.03	3.05	0.14	0.02
Other Current Assets	5.13	2.67	6.37	3.45	0.87	0.36
Total Current Assets	114.07	185.59	287.15	375.08	99.55	39.15
Property, Plant & Equipment	1.9	2.2	1.15	0.15	0.07	0.02
Long-Term Investments	79.12	91.66	6.76	27.76	8.04	22.95
Long-Term Deferred Charges	-	-	-	-	1.58	-
Other Long-Term Assets	2.43	2.72	3.13	7.34	0.34	-
Total Assets	197.52	293.48	305.44	414.17	111.55	62.12
Accounts Payable	4.88	4.59	2.4	6	3.08	0.69
Accrued Expenses	11.66	14.54	15.08	6.69	8.22	0.8
Current Portion of Leases	0.26	0.28	0.18	-	-	-
Current Income Taxes Payable	0.18	0.72	2.22	8.14	1	0.12
Other Current Liabilities	0.26	-	0.01	0.1	-	-
Total Current Liabilities	19.64	20.12	19.9	20.94	12.3	1.61
Long-Term Debt	22.74	20.28	17.52	3.14	2.18	0.16
Long-Term Leases	0.81	0.99	0.04	-	-	-
Other Long-Term Liabilities	8.02	7.78	2.22	4.13	1.71	0.57
Total Liabilities	51.2	49.16	39.68	28.21	16.18	2.34
Common Stock	18.77	18.57	18.56	18	13.37	6.57
Additional Paid-In Capital	808.36	794.79	774.09	725.05	261.63	73.07
Retained Earnings	-661.25	-550.94	-510.19	-357.8	-190	-19.46
Comprehensive Income & Other	-20.16	-19.46	-21.73	-8.34	5.82	-1.43
Total Common Equity	145.72	242.96	260.74	376.91	90.82	58.75
Minority Interest	0.6	1.35	5.03	9.05	4.55	1.03
Shareholders' Equity	146.32	244.32	265.77	385.96	95.37	59.78
Total Liabilities & Equity	197.52	293.48	305.44	414.17	111.55	62.12
Total Debt	26.21	21.54	17.74	3.14	2.18	0.16
Net Cash (Debt)	59.71	157.72	255.37	359.12	95.07	29.91
Net Cash Growth	-68.58%	-38.24%	-28.89%	277.75%	217.90%	-
Net Cash Per Share	0.37	0.99	1.64	2.60	1.02	3.45
Filing Date Shares Outstanding	167.8	166.03	166.01	160.71	11.47	9.07
Total Common Shares Outstanding	167.82	166.03	165.94	160.68	11.47	9.07
Working Capital	94.43	165.47	267.25	354.15	87.25	37.54
Book Value Per Share	0.87	1.46	1.57	2.35	7.92	6.48
Tangible Book Value	145.72	242.96	260.74	376.91	90.82	58.75
Tangible Book Value Per Share	0.87	1.46	1.57	2.35	7.92	6.48
Machinery	-	-	-	-	-	0.03

Source: S&P Capital IQ. Standard template. Financial Sources.